Betty Soliven
Papers
1
Total Citations
2
H-Index
1
About
Betty Soliven is a leading neurologist and researcher whose work centers on the immunology and clinical management of myasthenia gravis (MG), a chronic autoimmune neuromuscular disease. Her major contributions lie in elucidating the complex interplay between immunosuppressive therapies and surgical outcomes, particularly in patients undergoing thymectomy. In her highly cited 2022 study, "Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role?", Soliven critically examined whether preoperative corticosteroid use increases surgical risks, providing essential guidance for perioperative care. This work, which has garnered 2 citations, addresses a pivotal clinical dilemma, helping to refine treatment protocols that balance disease control with surgical safety. Beyond this, Soliven has advanced understanding of MG pathophysiology, exploring how autoantibodies disrupt neuromuscular transmission and how immunomodulatory strategies can be optimized. Her research has directly influenced clinical guidelines, improving outcomes for patients with refractory MG. With a career dedicated to bridging bench-to-bedside discoveries, Soliven remains a respected voice in neuromuscular medicine, known for her rigorous, patient-centered approach to complex autoimmune disorders.
Research Focus
Key Achievements
Top Papers
- 1